Selective targeting of RNA has become a recent priority in, drug desig
n strategies due to the emergence of retroviruses, the need for new an
tibiotics to counter drug resistance, and our increased awareness of t
he essential role RNA and RNA structures play in the progression of di
sease. Most organic compounds known to specifically target RNA are com
plex, naturally occurring antibiotics that are difficult to synthesize
or derivatize and modification of these compounds to optimize interac
tions with structurally unique RNAs is difficult. The de novo design o
f synthetically accessible analogues is one possible alternative; howe
ver, little is known about the RNA recognition principles on which to
design new compounds and limited information on RNA structure in gener
al is available. To contribute to the growing body of knowledge on RNA
recognition principles, we have prepared two series of polycationic R
NA-binding agents, one with a linear scaffold, the other with a macroc
yclic scaffold. We evaluated these compounds for their ability to bind
to DNA and RNA, as well as to a specific RNA, the regulatory sequence
, RRE, derived from HIV-1, by using thermal melting, circular dichrois
m, and electrophoresis gel shift methods. Our results suggest that cat
ionic charge centers of high pK(a) that are displayed along a scaffold
of limited flexibility bind preferentially to RNA, most likely within
the major groove. Related derivatives that bind more strongly to DNA
more closely mimic classical DNA minor-groove binding agents. Several
of the macrocyclic polycations expand on a new binding motif where pur
ine bases in duplex RNA are complexed within the macrocyclic cavity, e
nhancing base-pair opening processes and ultimately destabilizing the
RNA duplex. The results in this report should prove a helpful addition
to the growing information on molecular moths that specifically bind
to RNA. (C) 1997 Elsevier Science Ltd.